S. Magomedov

发表

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)

I. Efremova, V. Ivashkin, R. Maslennikov, 2021, European Cytokine Network.

Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection

A. Svistunov, O. Shifrin, M. Zharkova, 2021, Medicine.

ЕFFICIENCY OF DETERMINATION OF ACUTE PHASE PROTEINS AND PROCALCITONIN UNDER THE CONDITIONS OF SIMULATING INFECTIOUS ARTHRITIS

S. Magomedov, 2022, Biotechnologia Acta.

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19

I. Efremova, V. Ivashkin, R. Maslennikov, 2021, Pulmonary Pharmacology & Therapeutics.